関: U.S. Patent and Trademark Office

WordNet

obtain a patent for; "Should I patent this invention?"
an official document granting a right or privilege (同)letters_patent
a document granting an inventor sole rights to an invention (同)patent of invention
(of a bodily tube or passageway) open; affording free passage; "patent ductus arteriosus"
grant rights to; grant a patent for
make open to sight or notice; "His behavior has patented an embarrassing fact about him"
(of a government or government official) holding an office means being in power; "being in office already gives a candidate a great advantage"; "during his first year in office"; "during his first year in power"; "the power of the president" (同)power
place of business where professional or clerical duties are performed; "he rented an office in the new building" (同)business office
a religious rite or service prescribed by ecclesiastical authorities; "the offices of the mass"
professional or clerical workers in an office; "the whole office was late the morning of the blizzard" (同)office staff
register the trademark of; "The company trademarked their new gadget"
a formally registered symbol identifying the manufacturer or distributor of a product
the top of the head (同)poll, crown
liver or meat or fowl finely minced or ground and variously seasoned

PrepTutorEJDIC

『特許』,特許権,パテント / 『専売特許品』,特許となっている製法 / 専売特許証 / (一般に特権などを授ける)公式証書 / 《名詞の前にのみ用いて》専売特許の / 《名詞の前にのみ用いて》《英話》賢い,独特な,まねのできない / 明白な / …‘の'特許[権]を取る / …‘に'特許[権]を与える
〈C〉『事務所』,事務室;営業所,会社 / 《集合的に》《単数扱い》事務所(営業所)の全員 / 〈C〉〈U〉(特に政府・会社などの)『公職』,官職,職務 / 〈C〉(一般に)任務,務め,役目(duty) / 〈C〉『官庁』,役所;〈U〉《O-》《米》局,《英》省 / 〈C〉《複数形で》(…の)尽力,親切,世話《+『of』+『名』》 / 〈C〉《時にO-》(宗教上の)儀会,葬会;(定められた時間の)礼拝
《語・句・節を対等に結んで》…『と』…,…や…,および / 《数詞を結合して》…『足す』…,…に加えて / …『しかも』…,…して,同時に… / 《時間的に》『そして』,それから,すると(and then) / 《当然の帰結として》…『ので』,…だから(and so) / 《おもに話》《命令文などの後で》『そうすれば』,そうしたら / 《追加・強調して》それに,しかも / 《対照的な内容を導いて》ところが,しかし(but) / 《譲歩的に》それなのに,それでいながら / 《A and Bで一体の関係を表して》《単数扱い》 / 《同一語を反復して多数・継続などを表して》 / 《同一の複数名詞を結合して変化・種類などを表して》 / 《話》《「形容詞+and+形容詞」の形で前の形容詞が後に副詞的に働く》 / 《話》《「動詞come, goなど+and+動詞」の形でandとその後の動詞が不定詞の働きをして》 / 《「動詞+and+動詞」の形で後の動詞が現在分詞の意を表して》 / 《話》《文頭において前の質問・意見などに同意を示して》そうとも,そして(Yes!and) / 《話》《文頭に置いて驚き・疑念・非難などを表して》ほんとうに;…なのに
商標 / (ある人に特有の)行動様式 / …‘に'商標を付ける / …‘を'商標として登録する
頭,脳天;頭脳
パテ,肉パイ(レバー肉・魚などを小麦粉で練った菓子)

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/09/10 17:55:15」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 動脈管開存症のマネージメント management of patent ductus arteriosus
2. 小児救急のための診療準備 preparing an office practice for pediatric emergencies
3. 早産児における動脈管開存症の病態生理、臨床症状、および診断 pathophysiology clinical manifestations and diagnosis of patent ductus arteriosus in premature infants
4. Clinical manifestations and diagnosis of patent ductus arteriosus in term infants, children, and adults
5. 卵円孔開存 patent foramen ovale

English Journal

The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.

Wales M1, Cartier E1.
Cold Spring Harbor perspectives in medicine.Cold Spring Harb Perspect Med.2015 Sep 3. pii: a020925. doi: 10.1101/cshperspect.a020925. [Epub ahead of print]
One of the reasons that the United States is a leader in biotechnology is its strong and reliable patent system. However, the Supreme Court's decision in Myriad potentially limits an inventor's ability to protect her DNA-based inventions. Fortunately, with creativity, there are numerous ways in whic
PMID 26337114

Patentability of Stem Cells in the United States.

Fendrick SE1, Zuhn DL Jr1.
Cold Spring Harbor perspectives in medicine.Cold Spring Harb Perspect Med.2015 Aug 20. pii: a020958. doi: 10.1101/cshperspect.a020958. [Epub ahead of print]
Until recently, the patentability of stem cells was well established within the judicial and statutory framework in the United States. However, the shifting landscape of patent law, particularly with regard to patent-eligible subject matter under 35 U.S.C. §101, presents new challenges to the paten
PMID 26292987

Research and development of therapeutic mAbs: An analysis based on pipeline projects.

Geng X1, Kong X, Hu H, Chen J, Yang F, Liang H, Chen X, Hu Y.
Human vaccines & immunotherapeutics.Hum Vaccin Immunother.2015 Jul 25:0. [Epub ahead of print]
As the subject of active research and development (R&D) in recent decades, monoclonal antibodies have emerged among the major classes of therapeutic agents for treatment of many human diseases, especially cancers, infections, and immunological disorders. This article surveys the landscape of R&a
PMID 26211701